INTUITIVE SURGICAL INC
ISRG
74 insider filings · Latest: Oct 10, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Sep 16 5:35 PM | Fredrik WidmanVP Corporate Controller | Sale | 1,089 | $374.44 | $407.8K | 1,026(D) | View → |
| Sep 15, 2026 | Sep 15 8:43 PM | FREDRIK WIDMAN | Proposed Sale | 2,178 | $377.94 | $823.2K | — | View → |
| Sep 11, 2026 | Sep 11 10:41 PM | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sale | 25 | $365.79 | $9.1K | 764(D) | View → |
| Sep 10, 2026 | Sep 11 10:41 PM | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sale | 23 | $347.66 | $8.0K | 789(D) | View → |
| Sep 9, 2026 | Sep 9 10:45 PM | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sale | 23 | $350.20 | $8.1K | 812(D) | View → |
| Sep 8, 2026 | Sep 9 10:45 PM | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sale | 46 | $361.23 | $16.6K | 835(D) | View → |
| Sep 8, 2026 | Sep 8 8:29 PM | MARK BROSIUS | Proposed Sale | 694 | $366.70 | $254.5K | — | View → |
| Aug 21, 2026 | Aug 21 11:56 PM | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sale | 77 | $375.57 | $28.9K | 881(D) | View → |
| Aug 20, 2026 | Aug 21 11:56 PM | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sale | 77 | $396.37 | $30.5K | 958(D) | View → |
| Aug 19, 2026 | Aug 19 9:39 PM | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sale | 77 | $394.26 | $30.4K | 1,035(D) | View → |
| Aug 18, 2026 | Aug 19 9:39 PM | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sale | 77 | $394.00 | $30.3K | 1,112(D) | View → |
| Aug 17, 2026 | Aug 19 9:39 PM | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sale | 77 | $390.67 | $30.1K | 1,189(D) | View → |
| Aug 11, 2026 | Aug 12 5:22 PM | Gary S GuthartDirector | Sale | 10,000 | $400.00 | $4.0M | 1,245,679(I) | View → |
| Aug 11, 2026 | Aug 11 9:55 PM | Amy L LaddDirector | Sale | 72 | $393.10 | $28.3K | 179(D) | View → |
| Aug 10, 2026 | Aug 11 9:55 PM | Amy L LaddDirector | Sale | 400 | $379.00 | $151.6K | 251(D) | View → |
| Aug 11, 2026 | Aug 11 8:28 PM | GUTHART FAMILY TRUST | Proposed Sale | 20,095 | $393.38 | $7.9M | — | View → |
| Aug 10, 2026 | Aug 10 9:55 PM | Gary LoebEVP & Chief Legal and Complian | Sale | 400 | $379.00 | $151.6K | 5,320(D) | View → |
| Aug 10, 2026 | Aug 10 8:32 PM | AMY L LADD | Proposed Sale | 472 | $378.81 | $178.8K | — | View → |
| Aug 10, 2026 | Aug 10 8:31 PM | GARY LOEB | Proposed Sale | 400 | $378.81 | $151.5K | — | View → |
| Jul 31, 2026 | Jul 31 9:59 PM | Mark BrosiusEVP & Chief Mfg and Supply Cha | Sale | 28 | $351.00 | $9.8K | 1,266(D) | View → |
Page 1 of 9
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Feb 27 7:53 PM | Henry L CharltonEVP & Chief Commercial and Mkt | Grant/Award | 7,623 | $0.00 | 4,032(D) | View → |
| Feb 26, 2026 | Feb 27 7:45 PM | Jamie SamathEVP & CFO & Enterprise Technol | Option Exercise | 3,396 | $0.00 | 4,463(D) | View → |
| Feb 26, 2026 | Feb 27 7:45 PM | Jamie SamathEVP & CFO & Enterprise Technol | Grant/Award | 10,311 | $0.00 | 6,720(D) | View → |
| Feb 26, 2026 | Feb 27 7:36 PM | Gary LoebEVP & Chief Legal and Complian | Grant/Award | 4,634 | $0.00 | 3,584(D) | View → |
| Feb 26, 2026 | Feb 27 7:36 PM | Gary LoebEVP & Chief Legal and Complian | Option Exercise | 2,442 | $0.00 | 2,746(D) | View → |
| Feb 26, 2026 | Feb 27 7:00 PM | Curet MyriamEVP & Chief Medical Officer | Grant/Award | 2,793 | $0.00 | 8,378(D) | View → |
| Feb 26, 2026 | Feb 27 7:00 PM | Curet MyriamEVP & Chief Medical Officer | Option Exercise | 4,654 | $0.00 | 0(D) | View → |
| Feb 26, 2026 | Feb 27 6:52 PM | Fredrik WidmanVP Corporate Controller | Grant/Award | 1,627 | $0.00 | 1,627(D) | View → |
| Feb 26, 2026 | Feb 27 6:52 PM | Fredrik WidmanVP Corporate Controller | Option Exercise | 989 | $0.00 | 1,133(D) | View → |
| Feb 26, 2026 | Feb 27 6:42 PM | David J. RosaDirector, Chief Executive Officer (CEO) | Grant/Award | 21,247 | $0.00 | 13,441(D) | View → |
| Feb 26, 2026 | Feb 27 6:42 PM | David J. RosaDirector, Chief Executive Officer (CEO) | Option Exercise | 6,105 | $0.00 | 6,866(D) | View → |
| Feb 26, 2026 | Feb 27 6:32 PM | Gary S GuthartDirector | Grant/Award | 8,778 | $0.00 | 26,334(D) | View → |
| Feb 26, 2026 | Feb 27 6:32 PM | Gary S GuthartDirector | Option Exercise | 8,393 | $0.00 | 10,299(D) | View → |
| Feb 26, 2026 | Feb 27 6:19 PM | Mark BrosiusSVP & Chief Mfg and Supply Cha | Grant/Award | 7,721 | $0.00 | 4,928(D) | View → |
| Feb 26, 2026 | Feb 27 6:19 PM | Mark BrosiusSVP & Chief Mfg and Supply Cha | Option Exercise | 2,595 | $0.00 | 2,918(D) | View → |
| Feb 10, 2026 | Feb 11 10:37 PM | Curet MyriamEVP & Chief Medical Officer | Option Exercise | 943 | $229.39 | 838(D) | View → |
| Feb 10, 2026 | Feb 11 10:17 PM | Fredrik WidmanVP Corporate Controller | Option Exercise | 567 | $0.00 | 567(D) | View → |
| Feb 10, 2026 | Feb 10 9:28 PM | David J. RosaDirector, Chief Executive Officer (CEO) | Option Exercise | 1,436 | $0.00 | 1,436(D) | View → |
| Feb 10, 2026 | Feb 10 9:18 PM | Gary S GuthartDirector | Option Exercise | 2,633 | $0.00 | 2,633(D) | View → |
| Feb 10, 2026 | Feb 10 8:51 PM | Gary LoebEVP & Chief Legal and Complian | Option Exercise | 315 | $0.00 | 314(D) | View → |